Resources
Presentation
Dusquetide: Innate Defense Regulation as a Novel Approach to Antibiotic-Resistant Infection
Donini, O. Dusquetide: Innate Defense Regulation as a Novel Approach to Antibiotic-Resistant Infection. Presentation at BARDA TechWatch Meeting. August 2016.
Poster
Thermostable Lyophilized Ebola Vaccine Formulations
Chisholm, C.F., Kang, T.K., Lehrer, A., Donini, O.,, Randolph, T.W. Thermostable Lyophilized Ebola Vaccine Formulations. Poster presentation at the 2016 Workshop on Protein Aggregation and Immunogenicity. August 2-4, 2016.
Presentation
SGX942 Reduces the Duration of Severe Oral Mucositis
Donini O, Straube R. SGX942 Reduces the Duration of Severe Oral Mucositis. Presentation at 2016 Multinational Association for Supportive Care in Cancer Conference. June 23-25, 2016
Presentation
SGX942 Reduces the Duration of Severe Oral Mucositis
Donini O, Straube R. SGX942 Reduces the Duration of Severe Oral Mucositis. Presentation at 2016 Multinational Association for Supportive Care in Cancer Conference. June 23-25, 2016
Poster
An Innate Defense Regulator for the Treatment of Macrophage Activation Syndrome: Preclinical Studies in an Orphan Indication
Donini O, Behrens E, Haulenbeek A, Pullion C, Schaber C. An Innate Defense Regulator for the Treatment of Macrophage Activation Syndrome: Preclinical Studies in an Orphan Indication. Poster Presentated at the National Organization for Rare Diseases (NORD) Rare Diseases and Orphan Products Breakthrough Summit. 2016.
Poster
SGX942 REDUCES THE DURATION OF SEVERE ORAL MUCOSITIS
Donini O, Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Elder J. SGX942 Reduces the Duration of Severe Oral Mucositis. Poster presented at the 25th Multinational Association of Supportive Care in Cancer. 2016.
Poster
An Innate Defense Regulator for the Treatment of Macrophage Activation Syndrome: Preclinical Studies in an Orphan Indication
Donini O, Behrens E, Haulenbeek A, Pullion C, Schaber C. An Innate Defense Regulator for the Treatment of Macrophage Activation Syndrome: Preclinical Studies in an Orphan Indication. Poster Presentated at the National Organization for Rare Diseases (NORD) Rare Diseases and Orphan Products Breakthrough Summit. 2016.
Poster
SGX942 Reduces the Duration of Severe Oral Mucositis
Donini O, Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Elder J. SGX942 Reduces the Duration of Severe Oral Mucositis. Poster presented at the 25th Multinational Association of Supportive Care in Cancer. 2016.
Paper
A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy
North JR, Takenaka S, Rozek A, Kielczewska A, Opal S, Morici L, Finlay BB, Schaber CJ, Straube R, Donini O. A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy. J Biotech 2016; 226: 24-34.
Paper
A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy
North JR, Takenaka S, Rozek A, Kielczewska A, Opal S, Morici L, Finlay BB, Schaber CJ, Straube R, Donini O. A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy. J Biotech 2016; 226: 24-34.